Search NLS News

ACELYRIN has announced that the global Phase 2b/3 clinical trial of izokibep in psoriatic arthritis (PsA) met its primary endpoint with high statistical significance. Positive long-term data from a Phase 2b clinical trial in hidradenitis suppurativa (HS) were also announced. In the Phase 2b/3 PsA trial the primary endpoint of ACR50 at week 16 was […]

The company will establish a new laboratory in Uppsala, Sweden, during the spring. The lab will be well-equipped for vaccine development, with instrumentation that enables the company to develop more vaccine candidates in a faster and more cost-effective manner, states the company. “Abera’s operations have evolved significantly in recent years, transitioning from discovery research to […]

Fredrik Almqvist and Marta Bally have been appointed as the new Directors of UCMR, the hub for microbial infection research at Umeå University. Their forward agenda includes enhancing collaboration with clinical research and establishing Biosafety Level 3 (BSL-3) labs for both in vitro and in vivo experiments, reports Umeå Biotech Incubator. Fredrik Almqvist and Marta […]

Sahlgrenska Science Park, GoCo Health Innovation City, AstraZeneca, and other members of Health Innovation West are inviting to a femtech innovation hackathon, a hackaton focused on reducing the gender health gap and advancing women’s health. A hackaton focused on reducing the gender health gap and advancing women’s health.” Using generative AI tools, HackHERHealth is set […]

On International Women’s Day we like to highlight some of the many inspiring women in life science that we have had the opportunity to meet and interview.     Bahija Jallal I definitely think it’s important for women in life science to have role models. I have always had mentors and tried to pay that […]

The combined treatment of UV1 with ipilimumab and nivolumab showed similar clinical benefits as treatment with ipilimumab and nivolumab alone, meaning the primary and secondary endpoints of the study were not met. Ultimovacs has reported results from the Phase II clinical trial, INITIUM, evaluating the company’s therapeutic cancer vaccine candidate UV1 as first-line treatment in […]

The 2024 Uppsala University Innovation and Entrepreneurship Prize has been awarded to Mats Karlsson, Professor of Pharmacometrics and co-founder of Pharmatheus. The citation for the prize, which will be presented in April, reads as follows: “Together with his research team, he has successfully transformed academic excellence from a world-class research environment into a prominent and […]

Via the agreement, the enhancing effect of the iTANK-technology will be evaluated in a novel T-cell receptor therapy targeting skin cancer and lung cancer. As per the agreement, Elicera Therapeutics will make parts of its technology iTANK available to a medical oncologist and researcher at the US Cancer Center whose investigation focuses on the development […]

The Board of Directors of Atlas Antibodies has appointed Ingela Hofverberg as the new CEO. Ingela Hofverberg joined Atlas Antibodies in August 2022 and has held several roles during her tenure, including Chief Transformation & Quality Officer and Chief Financial Officer, and has most recently served as the acting interim CEO of Atlas BU since […]

The board of Calmark Sweden has decided to file for bankruptcy. The board’s decision is based on the company’s strained and urgent liquidity needs in both the short and long term. In-depth dialogues with intended cooperation partners have not been able to be completed, states the company. The Board of Directors assesses that the warrants […]